Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.870
+0.030 (1.63%)
At close: Mar 4, 2026
Cannara Biotech Revenue
Cannara Biotech had revenue of 30.11M CAD in the quarter ending November 30, 2025, with 20.11% growth. This brings the company's revenue in the last twelve months to 112.36M, up 28.06% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth.
Revenue (ttm)
112.36M
Revenue Growth
+28.06%
P/S Ratio
1.65
Revenue / Employee
248.33K
Employees
452
Market Cap
184.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 107.32M | 25.17M | 30.64% |
| Aug 31, 2024 | 82.15M | 24.59M | 42.71% |
| Aug 31, 2023 | 57.56M | 21.57M | 59.91% |
| Aug 31, 2022 | 36.00M | 18.73M | 108.48% |
| Aug 31, 2021 | 17.27M | 15.17M | 723.42% |
| Aug 31, 2019 | 2.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tidewater Midstream and Infrastructure | 1.37B |
| Genesis Land Development | 351.20M |
| Blue Ant Media | 235.71M |
| DIRTT Environmental Solutions | 231.52M |
| Tiny Ltd. | 199.65M |
| Yellow Pages | 198.88M |
| Largo | 155.84M |
| D-BOX Technologies | 51.55M |